| Financial Year |
March 31 2023 |
| Monetary Funds |
548,749,945.14 |
| Held-for-trading Financial Assets |
80,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
570,219,291.25 |
| Advances to Suppliers |
8,365,788.43 |
| Other Receivables |
9,714,532.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
235,040,482.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,810,044.56 |
| Total Current Assets |
1,565,520,440.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,584,089.55 |
| Investment Properties |
-- |
| Fixed Assetes |
265,439,611.17 |
| Under-construction Projects |
223,273,986.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,857,247.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
108,961.96 |
| Deferred Income Tax Assets |
31,739,416.43 |
| Other Non-Current Assets |
11,558,473.76 |
| Sub-Total of Non-Current Assets |
596,715,807.82 |
| Total Assets |
2,162,236,248.69 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
268,724,588.93 |
| Accounts Received In Advance |
53,529.00 |
| Employee Compensation Payable |
8,459,567.61 |
| Taxes Payable |
2,293,687.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,214,097.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,413,489.62 |
| Other Current Liabilities |
1,976,270.98 |
| Sub-Total of Current Liabilities |
428,337,507.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,316,054.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,840,383.82 |
| Total Liabilities |
460,177,890.83 |
| Paid-In Capital(Or Share Stock) |
193,107,640.00 |
| Capital Surplus |
710,866,002.85 |
| Surplus Reserve |
107,457,819.36 |
| LESS:Treasury Stock |
127,399,707.55 |
| Undistributed Profits |
818,026,603.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,702,058,357.86 |
| Owner's Equity（Stockholder's Equity） |
1,702,058,357.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,162,236,248.69 |
